![]()
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
E. H. Romond
and Others
- 20 Oct, 2005
This
PowerPoint Slide Set is a value
added service that requires an individual subscription.
Already a print subscriber? Activate your online access
Not a Subscriber?
Get full access to NEJM Online now with a FREE TRIAL!
Or, purchase full access to this
PowerPoint Slide Set for $10